Skip to main content
. 2012 Mar;1(1):19–32. doi: 10.3978/j.issn.2223-4683.2012.01.03

Figure 1.

Figure 1

Diagrammatic illustration of therapies that target primary prostate tumor cells, CRPC, cells (stromal/endothelial/immune cells) and soluble factors in tumor microenvironment of the prostate and the bone.